Qualigen Therapeutics, Inc. QLGN
3.21 0.00 0.00%
At close · Nov 18
- YTD
- -23.75%
- 1 year
- -11.81%
- Open
- 2.98
- Prev close
- 3.21
- Mkt cap
- 2.98M
- Vol
- 368.77K
- Avg vol
- 92.24K
- EPS
- 3,635.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.86
- High
- 3.34
- Forward P/E
- -4.04
- Beta
- 0.14
- Short ratio
- 0.11
- Inst. own
- 1.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 7, 2024
- 50-d avg
- 5.21
- 200-d avg
- 10.89
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for QLGN has not been loaded yet. Try again in a moment.
Altman Z-Score
-33.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.4×
P/S 0.0×
P/B 0.2×
P/FCF -1.0×
EV/EBITDA 0.9×
EV/Sales 0.0×
FCF Yield -100.2%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -69.9%
ROIC -47.0%
ROA -62.4%
Revenue 0.0%
Operating Income -129.1%
EPS (diluted) 53.1%
Free Cash Flow -9.9%
Current Ratio 9.3×
Quick Ratio 9.3×
Debt / Equity 0.0×
Net Debt / EBITDA 1.5×
Interest Coverage -13.4×
Dividend Yield 37.0%
Payout Ratio -13.1%
Annual · latest fiscal year ends 2025-12-31